Novel PD-1 blockade bioassay to assess therapeutic antibodies in PD-1 and PD-L1 immunotherapy programs

被引：9
|
作者：
Cheng, Zhi-Jie Jey [1 ]
Karassina, Natasha [1 ]
Grailer, Jamison [1 ]
Hartnett, Jim [1 ]
Fan, Frank [1 ]
Cong, Mei [1 ]
机构：
[1] Promega Corp, Madison, WI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5440
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5440
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies
    Sakakida, T.
    Ishikawa, T.
    Chihara, Y.
    Harita, S.
    Uchino, J.
    Tabuchi, Y.
    Komori, S.
    Asai, J.
    Narukawa, T.
    Arai, A.
    Tsunezuka, H.
    Kosuga, T.
    Konishi, H.
    Moriguchi, M.
    Yasuda, H.
    Hongo, F.
    Inoue, M.
    Hirano, S.
    Ukimura, O.
    Itoh, Y.
    Taguchi, T.
    Takayama, K.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06): : 919 - 927
  • [42] Molecular interactions of antibodies with PD-1/PD-L1 proteins
    Vasilakaki, Sofia
    Vathiotis, Ioannis
    Panagiotou, Emmanouil
    Dimakakos, Evangelos
    Gomatou, Georgia
    Kotteas, Elias
    IMMUNOTHERAPY, 2024, 16 (01) : 21 - 28
  • [43] Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
    Chen, Miaomiao
    Zhou, Yuli
    Bao, Kaicheng
    Chen, Siyu
    Song, Guoqing
    Wang, Siliang
    BIODRUGS, 2025,
  • [44] Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies
    T. Sakakida
    T. Ishikawa
    Y. Chihara
    S. Harita
    J. Uchino
    Y. Tabuchi
    S. Komori
    J. Asai
    T. Narukawa
    A. Arai
    H. Tsunezuka
    T. Kosuga
    H. Konishi
    M. Moriguchi
    H. Yasuda
    F. Hongo
    M. Inoue
    S. Hirano
    O. Ukimura
    Y. Itoh
    T. Taguchi
    K. Takayama
    Clinical and Translational Oncology, 2020, 22 : 919 - 927
  • [45] Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
    Bingshan Liu
    Yongping Song
    Delong Liu
    Journal of Hematology & Oncology, 10
  • [46] Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy
    Liu, Bingshan
    Song, Yongping
    Liu, Delong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [47] The impact of oncolytic adenoviral therapy on the therapeutic efficacy of PD-1/PD-L1 blockade
    Najafi, Sajad
    Majidpoor, Jamal
    Mortezaee, Keywan
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [48] Multispecific Antibodies Targeting PD-1/PD-L1 in CancerMultispecific Antibodies Targeting PD-1/PD-L1 in CancerM. Chen et al.
    Miaomiao Chen
    Yuli Zhou
    Kaicheng Bao
    Siyu Chen
    Guoqing Song
    Siliang Wang
    BioDrugs, 2025, 39 (3) : 427 - 444
  • [49] Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN- production via PD-1/PD-L1 blockade in bovine mycoplasmosis
    Goto, Shinya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nishimori, Asami
    Maekawa, Naoya
    Gondaira, Satoshi
    Higuchi, Hidetoshi
    Koiwa, Masateru
    Tajima, Motoshi
    Kohara, Junko
    Ogasawara, Satoshi
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) : 355 - 363
  • [50] New strategies with PD-1/PD-L1 blockade in lung cancer
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (SUPPL 3) : 54 - 58
12345